http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PH-12016500125-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef4f341fe4f2caf061611a818576e40
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C57-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C57-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4725
filingDate 2016-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea4a951f17af953a2c8ccb5e87e16951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb5b142cd14c3899221ac21b0379f620
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ec29a32ba3c93e0dedaf8636bdbb36f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03a20da42227a7bdf3bb976fe7e94a5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_461f6bc4f10b1e1f0a9f58950cbe5e67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abd04258367e42d2faba5326612aae50
publicationDate 2016-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PH-12016500125-B1
titleOfInvention Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1h)-one derivatives having both muscarinic receptor antagonist and 2 adrenergic receptor agonist activities
abstract The present invention is directed to crystalline addition salts of (i) 8-hydroxyquinolin- 2(1H)-one derivatives and (ii) a dicarboxylic acid or a sulfimide, or a pharmaceutically acceptable solvates thereof.
priorityDate 2013-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID140722373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID97250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429451061

Total number of triples: 40.